Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Population pharmacokinetics of piperacillin/tazobactam and vancomycin in neonates and young infants
ChiCTR-ONRC-12002262Phase 4Completed
- Sponsor
- Children's Hospital of Fudan University
- Start
- Mar 2011
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of piperacillin + tazobactam and vancomycin in bacterial disease (2 arms), sponsored by Children's Hospital of Fudan University. Primary endpoint: Drug concentration detection. Started Mar 2011; status: completed.
02
Drugs
piperacillin + tazobactamvancomycin
03
Conditions
bacterial disease
Beyond the preview
Go deeper on ChiCTR-ONRC-12002262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONRC-12002262.